M&A Deal Summary |
|
|---|---|
| Date | 2008-06-18 |
| Target | AB BIODISK |
| Sector | Life Science |
| Buyer(s) | bioMerieux |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1963 |
| Sector | Life Science |
| Employees | 14,147 |
| Revenue | 4.0B EUR (2024) |
bioMerieux is a provider in the field of in vitro diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening, monitoring, and cardiovascular emergencies. bioMerieux was founded in 1963 and is based in Marcy-l'Étoile, France.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 21 |
| Sector: Life Science M&A | 5 of 11 |
| Type: Add-on Acquisition M&A Deals | 6 of 17 |
| Country: Sweden M&A | 1 of 1 |
| Year: 2008 M&A | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-09-11 |
BTF Pty.
North Ryde, Australia BTF Pty. Ltd. is a specialist in industrial microbiology. BTF provides most precise quantitative reference standards for microbiological testing. Its patented BioBall™ technology is used in quality assurance, to verify the performance of control methods. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-09-11 |
AviaraDX
San Diego, California, United States AviaraDX, Inc. is a developing and commercializing molecular diagnostic technologies for personalized medicine in cancer treatment. |
Buy | $60M |
